iNtRON Biotechnology, Inc. (048530.KQ)
KRW 5500.0
(-4.35%)
KRW 5500.0
(-4.35%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 3.47 Billion | 6 Billion | 16.55 Billion | 7.13 Billion | -812.48 Million | 4.2 Billion |
| Net Income | -9.69 Billion | 5.71 Billion | 9.72 Billion | 14.94 Billion | -3.18 Billion | 8.71 Billion |
| Depreciation & Amortization | 1.91 Billion | 1.56 Billion | 1.53 Billion | 1.56 Billion | 1.42 Billion | 940.44 Million |
| Deferred income taxes | -2.11 Billion | -5.63 Billion | - | - | - | - |
| Stock-based compensation | 377.76 Million | 360.17 Million | - | - | - | - |
| Change in working capital | 1.53 Billion | 3.01 Billion | 2.77 Billion | -10.02 Billion | 1.29 Billion | -2.9 Billion |
| Other non-cash items | 11.57 Billion | -6.87 Billion | 3.65 Billion | 13.44 Billion | 4.63 Million | -870.57 Million |
| Investing Cash Flow | 51.79 Billion | -46.25 Billion | -41.36 Billion | 2.29 Billion | -4.51 Billion | -1.26 Billion |
| Investments in PPE | -9.55 Billion | -2.61 Billion | -3.49 Billion | -6.07 Billion | -672.89 Million | -733.39 Million |
| Acquisitions | 9 Million | - | 15 Million | -56.6 Million | - | 53.63 Million |
| Investment purchases | -6.93 Billion | -66.84 Billion | -40.7 Billion | -11.1 Billion | -11.15 Billion | -6.61 Billion |
| Sales/Maturities of investments | 68.2 Billion | 23.17 Billion | 2.62 Billion | 19.11 Billion | 7.25 Billion | 6.13 Billion |
| Other Investing Activities | 66.41 Million | 42.56 Million | 199.9 Million | 423.46 Million | 52.58 Million | -101.85 Million |
| Financing Cash Flow | -40.16 Billion | -9.19 Billion | 39.74 Billion | -2 Billion | 37.31 Billion | 1.97 Billion |
| Debt repayment | -40 Billion | -196.82 Million | -40 Billion | -1.61 Billion | -36.52 Billion | -446.01 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -8.99 Billion | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -168.09 Million | -10 Thousand | -13.55 Thousand | -38.42 Thousand | 1.17 Billion | 2.42 Billion |
| Accounts receivables | 2.37 Billion | 5.96 Billion | 1.1 Billion | -9.45 Billion | 2.26 Billion | 679.86 Million |
| Accounts payables | -99.72 Million | -465.36 Million | 354.35 Million | -57.51 Million | 107.04 Million | -151.48 Million |
| Inventory | -306.33 Million | 217.09 Million | 479.08 Million | -154.44 Million | 124.13 Million | -318.55 Million |
| Other working capital | -437.15 Million | -2.7 Billion | 829.45 Million | -359.96 Million | -1.19 Billion | -3.11 Billion |
| Cash at beginning of period | 25.81 Billion | 75.17 Billion | 59.92 Billion | 53.32 Billion | 21.12 Billion | 15.75 Billion |
| Cash at end of period | 40.98 Billion | 25.81 Billion | 75.17 Billion | 59.92 Billion | 53.32 Billion | 21.12 Billion |
| Capital Expenditure | -9.55 Billion | -2.61 Billion | -3.49 Billion | -6.07 Billion | -672.89 Million | -733.39 Million |
| Effect of forex changes on cash | 72.74 Million | 76.58 Million | 298.73 Million | -906.99 Million | 46.39 Million | 77.38 Million |
| Net cash flow / Change in cash | 15.17 Billion | -49.35 Billion | 15.24 Billion | 6.59 Billion | 32.2 Billion | 5.37 Billion |
| Free Cash Flow | -6.07 Billion | 3.38 Billion | 13.06 Billion | 1.06 Billion | -1.48 Billion | 3.46 Billion |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 579.25 Million | -375.81 Million | -3.7 Billion | -9.69 Billion | -2.59 Billion | -1.84 Billion |
| Depreciation & Amortization | 518.39 Million | 525.66 Million | 522.87 Million | 1.91 Billion | 484.22 Million | 403.06 Million |
| Deferred income taxes | - | - | -2.48 Billion | -2.11 Billion | 474.93 Million | -1.02 Billion |
| Stock-based compensation | - | 17.59 Million | 95.21 Million | 377.76 Million | 95.21 Million | 94.18 Million |
| Change in working capital | -2.54 Billion | 3.3 Billion | -220.71 Million | 1.53 Billion | 403.88 Million | 682.11 Million |
| Other non-cash items | -1.28 Billion | 472.07 Million | 6.66 Billion | 11.57 Billion | 1.51 Billion | 2.13 Billion |
| Investing Cash Flow | -3.49 Million | 2.92 Billion | -11.8 Billion | 51.79 Billion | 4.37 Billion | 54.77 Billion |
| Investments in PPE | -79.51 Million | -44.13 Million | -8.17 Billion | -9.55 Billion | -895.63 Million | -331.61 Million |
| Acquisitions | 2.19 Billion | 40.48 Million | - | 9 Million | 500 Thousand | 8.5 Million |
| Investment purchases | -2.27 Billion | -591.15 Million | -3.69 Billion | -6.93 Billion | -3.08 Billion | -48.23 Million |
| Sales/Maturities of investments | -377.07 Thousand | 3.48 Billion | - | 68.2 Billion | 8.35 Billion | 55.14 Billion |
| Other Investing Activities | -3.49 Million | 40.14 Million | 65.21 Million | 66.41 Million | -1.86 Million | -140 Thousand |
| Financing Cash Flow | -808.61 Million | -3.35 Billion | -40.13 Million | -40.16 Billion | -40.04 Billion | -42.37 Million |
| Debt repayment | -49.11 Million | -37.28 Million | -40.13 Million | -40 Billion | -40 Billion | -42.37 Million |
| Dividends payments | - | -3.31 Billion | - | - | - | - |
| Common Stock Repurchased | -759.5 Million | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -49.11 Million | - | -40.13 Million | -168.09 Million | -40.04 Billion | -42.37 Million |
| Accounts receivables | 508.39 Million | 454.28 Million | -1.12 Billion | 2.37 Billion | 1.7 Billion | 834.49 Million |
| Accounts payables | -9.99 Million | 118.74 Million | -299.48 Million | -99.72 Million | 165.59 Million | 66.13 Million |
| Inventory | -200.83 Million | 56.38 Million | 55.31 Million | -306.33 Million | -355.43 Million | 103.19 Million |
| Other working capital | -2.85 Billion | 2.67 Billion | 1.15 Billion | -437.15 Million | -1.1 Billion | -321.71 Million |
| Cash at beginning of period | 44.28 Billion | 40.98 Billion | 52.17 Billion | 25.81 Billion | 87.38 Billion | 31.08 Billion |
| Cash at end of period | 40.7 Billion | 44.28 Billion | 40.98 Billion | 40.98 Billion | 52.17 Billion | 87.38 Billion |
| Capital Expenditure | -79.51 Million | -44.13 Million | -8.17 Billion | -9.55 Billion | -895.63 Million | -331.61 Million |
| Effect of forex changes on cash | -32.36 Million | 215.99 Million | -185.19 Million | 72.74 Million | 103.41 Million | 72.53 Million |
| Net cash flow / Change in cash | -3.58 Billion | 3.29 Billion | -11.18 Billion | 15.17 Billion | -35.21 Billion | 56.3 Billion |
| Free Cash Flow | -2.81 Billion | 3.46 Billion | -7.32 Billion | -6.07 Billion | -544.5 Million | 1.24 Billion |
RBRXF
BAS
DXIEF
ALNXT
HEBA-B
BTDR